Generics Access Project

Advocating for policies that promote generic competition and
efficient approval of generic medicines.

[Generics Access Project @GenericsProject]

This week's GAP steering committee spotlight is the Color of Crohn's & Chronic Illness. Their mission is to improve the quality of life for BIPOC who are affected by IBD, digestive disorders & associated chronic illnesses. Learn more about @colorofgi: https://t.co/viMgU2gjtk

[Generics Access Project @GenericsProject]

Over the next few weeks, GAP will be reintroducing members of its steering committee individually.

These member organizations comprise the Generics Access Project and work together to drive our mission of improving patient access to affordable #generic drugs.

Stay tuned!

[Generics Access Project @GenericsProject]

✅ First up for GAP's steering committee spotlights is @AllergyAsthmaHQ

The Allergy & Asthma Network's mission is to improve the lives of people living with asthma, allergies and related conditions.

Learn more here: https://t.co/PCb57xfPdh

[Generics Access Project @GenericsProject]

Introducing another GAP steering committee member: the Coalition of Skin Diseases. Their mission is to foster education & awareness of skin diseases and disorders and advocate for quality health care.

Learn more about @USskincoalition: https://t.co/F39Ku6zVIL

[Generics Access Project @GenericsProject]

Introducing another GAP steering committee member spotlight: the Asthma & Allergy Foundation of America. Their mission is to reduce the burden of disease for people with asthma and allergies through advocacy, education and research.

Learn more about AAFA: https://t.co/3qm8zWX3Ra

[Generics Access Project @GenericsProject]

GAP is happy to introduce another steering committee member: @patientaccess

AfPA's mission is to promote a better understanding of the benefits of the physician-patient relationship in the provision of quality health care.

Learn more: https://t.co/oAd2sVOsXk

[Generics Access Project @GenericsProject]

GAP focuses on improving timely patient access to #genericdrugs, promoting efficient approvals, and ensuring the FDA prioritizes unmet patient needs and listens to the patient perspective.

Visit GAP's website to learn more & sign up for the newsletter: https://t.co/g7HwJZYzCy

[Generics Access Project @GenericsProject]

#DYK? Patients, and the U.S. health care system, have benefited significantly from increased access to generic drugs. Generics account for 90% of U.S. prescription volume but only 12% of total prescription drug spending.

Learn more: https://t.co/qz6JJSSoMx

[Generics Access Project @GenericsProject]

What is a drug shortage?

According to the FDA, a drug shortage occurs when demand or projected demand for a drug within the United States exceeds supply for a period of time.

Learn more: https://t.co/HAx32l4V5y

[Generics Access Project @GenericsProject]

Join the Generics Access Project to participate in GDUFA discussions with the FDA and help advance patient access to safe, effective and affordable medicines.

Learn more: https://t.co/qz6JJSSoMx

[Generics Access Project @GenericsProject]

#DYK? 9 out of 10 prescriptions filled in the United States are for generic drugs.

Learn more about why access matters: https://t.co/OVPbOifSsM

[Generics Access Project @GenericsProject]

Patients shouldn't have to pay the price of drug shortages.

Learn more: https://t.co/cGjuAUc4oX

[Generics Access Project @GenericsProject]

GAP will continue to champion patient priorities throughout the GDUFA IV process, including the need for transparent quality standards, and meaningful patient involvement in policies that influence generic drug availability and affordability.

Learn more: https://t.co/qz6JJSSoMx

[Generics Access Project @GenericsProject]

Generic drugs save the health care system billions of dollars every year and help increase access to medicine. With greater awareness and more
education, generics can benefit still more patients across the country.

Learn more: https://t.co/5rprWWgqC4

[Generics Access Project @GenericsProject]

DYK? #GenericDrugs are approved by the @FDA in 5️⃣ steps. They are:

✅ Safety & Efficacy
✅ Bioequivalence
✅ Quality & Manufacturing
✅ Labeling & Packaging
✅ Approval Decision

Learn more: https://t.co/jEc33Xy1q8

[Generics Access Project @GenericsProject]

DYK? #SkinnyLabeling allows generic drugs to enter the market sooner, meaning patients can benefit from:

🟣 Lower drug prices
🟣 More treatment options
🟣 Increased competition

Learn more in GAP's one-pager: https://t.co/vQLJiIMZBk

[Generics Access Project @GenericsProject]

#DYK? The @FDA's Office of Generic Drugs within the Center for Drug Evaluation in Research ensures high-quality, affordable generic drugs are available to the American public by following a rigorous review process.

Learn more: https://t.co/ZCnGCZ909t

[Generics Access Project @GenericsProject]

#DYK? #GenericDrugs are approved by the @FDA in 5️⃣ steps. They are:

❇️ Safety & Efficacy
❇️ Bioequivalence
❇️ Quality & Manufacturing
❇️ Labeling & Packaging
❇️ Approval Decision

Learn more: https://t.co/jEc33Xy1q8

[Generics Access Project @GenericsProject]

#DYK? 9 out of 10 prescriptions filled in the United States are for generic drugs.

🟣 Most are for simple oral medications
🟣 More complex generics are on the way

Learn more: https://t.co/OVPbOifSsM

[Generics Access Project @GenericsProject]

What are complex #generics?

Watch now to find out: